KR100462441B1 - 성 호르몬 및 시클로덱스트린을 포함하는 비강 분무액을 제조하는 방법 - Google Patents
성 호르몬 및 시클로덱스트린을 포함하는 비강 분무액을 제조하는 방법 Download PDFInfo
- Publication number
- KR100462441B1 KR100462441B1 KR10-2001-7004679A KR20017004679A KR100462441B1 KR 100462441 B1 KR100462441 B1 KR 100462441B1 KR 20017004679 A KR20017004679 A KR 20017004679A KR 100462441 B1 KR100462441 B1 KR 100462441B1
- Authority
- KR
- South Korea
- Prior art keywords
- solution
- cyclodextrin
- estradiol
- purified water
- hormone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- Nanotechnology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biophysics (AREA)
- Reproductive Health (AREA)
- Otolaryngology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9812836A FR2784584B1 (fr) | 1998-10-14 | 1998-10-14 | Procede de preparation d'une solution pour pulverisation nasale contenant une ou plusieurs hormones sexuelles et une cyclodextrine |
| FR98/12836 | 1998-10-14 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20010073214A KR20010073214A (ko) | 2001-07-31 |
| KR100462441B1 true KR100462441B1 (ko) | 2004-12-17 |
Family
ID=9531516
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR10-2001-7004679A Expired - Fee Related KR100462441B1 (ko) | 1998-10-14 | 1999-10-13 | 성 호르몬 및 시클로덱스트린을 포함하는 비강 분무액을 제조하는 방법 |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1121100B1 (https=) |
| JP (1) | JP3911125B2 (https=) |
| KR (1) | KR100462441B1 (https=) |
| CN (1) | CN1323198A (https=) |
| AT (1) | ATE237310T1 (https=) |
| AU (1) | AU756441B2 (https=) |
| BR (1) | BR9914532A (https=) |
| CA (1) | CA2346567C (https=) |
| DE (1) | DE69907005T2 (https=) |
| DK (1) | DK1121100T3 (https=) |
| EA (1) | EA003069B1 (https=) |
| ES (1) | ES2197672T3 (https=) |
| FR (1) | FR2784584B1 (https=) |
| HK (1) | HK1040201A1 (https=) |
| HU (1) | HUP0103968A3 (https=) |
| NO (1) | NO20011673D0 (https=) |
| NZ (1) | NZ510776A (https=) |
| PL (1) | PL347322A1 (https=) |
| PT (1) | PT1121100E (https=) |
| WO (1) | WO2000021503A1 (https=) |
| ZA (1) | ZA200102961B (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2827516B1 (fr) * | 2001-07-19 | 2003-09-19 | Servier Lab | Composition pharmaceutique pour l'administration par voie nasale d'estradiol et de norethisterone |
| EP1661556A4 (en) * | 2003-08-20 | 2010-05-19 | Ajinomoto Kk | MEDICAL PREPARATION WITH IMPROVED RESOLUTION CHARACTERISTICS |
| GB2482868A (en) * | 2010-08-16 | 2012-02-22 | Franciscus Wilhelmus Henricus Maria Merkus | A testosterone liquid spray formulation for oromucosal administration |
| EA201490746A3 (ru) * | 2011-10-07 | 2016-09-30 | Флорида Стейт Юниверсити Рисеч Фондэйшн | Применение прогестерона при профилактике и после острого периода для улучшения исходов, связанных с сотрясением мозга |
| CA2863500A1 (en) | 2012-01-20 | 2013-07-25 | Aratana Therapeutics Nv | Eye drop composition |
| RU2753511C2 (ru) * | 2017-05-31 | 2021-08-17 | Аратана Терапьютикс, Инк. | Композиция глазных капель |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL8801670A (nl) * | 1988-07-01 | 1990-02-01 | Walter Adrianus Josephus Johan | Farmaceutisch preparaat. |
| US5376645A (en) * | 1990-01-23 | 1994-12-27 | University Of Kansas | Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
| GB9012663D0 (en) * | 1990-06-07 | 1990-08-01 | Erba Carlo Spa | Galenic formulations containing cyclodextrins |
| DE4207922A1 (de) * | 1992-03-13 | 1993-09-23 | Pharmatech Gmbh | Wasserloesliche einschlussverbindungen und verfahren zu deren herstellung |
| BE1007402A5 (nl) * | 1993-03-26 | 1995-06-06 | Adir | Nasale farmaceutische preparaten met progestagene stof. |
-
1998
- 1998-10-14 FR FR9812836A patent/FR2784584B1/fr not_active Expired - Fee Related
-
1999
- 1999-10-13 PL PL99347322A patent/PL347322A1/xx unknown
- 1999-10-13 CN CN99812123A patent/CN1323198A/zh active Pending
- 1999-10-13 AU AU60967/99A patent/AU756441B2/en not_active Ceased
- 1999-10-13 WO PCT/FR1999/002480 patent/WO2000021503A1/fr not_active Ceased
- 1999-10-13 AT AT99947567T patent/ATE237310T1/de not_active IP Right Cessation
- 1999-10-13 JP JP2000575479A patent/JP3911125B2/ja not_active Expired - Fee Related
- 1999-10-13 BR BR9914532-4A patent/BR9914532A/pt not_active Application Discontinuation
- 1999-10-13 HK HK02102010.0A patent/HK1040201A1/zh unknown
- 1999-10-13 HU HU0103968A patent/HUP0103968A3/hu unknown
- 1999-10-13 EA EA200100316A patent/EA003069B1/ru not_active IP Right Cessation
- 1999-10-13 ES ES99947567T patent/ES2197672T3/es not_active Expired - Lifetime
- 1999-10-13 DK DK99947567T patent/DK1121100T3/da active
- 1999-10-13 DE DE69907005T patent/DE69907005T2/de not_active Expired - Fee Related
- 1999-10-13 NZ NZ510776A patent/NZ510776A/xx unknown
- 1999-10-13 CA CA002346567A patent/CA2346567C/fr not_active Expired - Fee Related
- 1999-10-13 KR KR10-2001-7004679A patent/KR100462441B1/ko not_active Expired - Fee Related
- 1999-10-13 EP EP99947567A patent/EP1121100B1/fr not_active Expired - Lifetime
- 1999-10-13 PT PT99947567T patent/PT1121100E/pt unknown
-
2001
- 2001-04-03 NO NO20011673A patent/NO20011673D0/no not_active Application Discontinuation
- 2001-04-10 ZA ZA200102961A patent/ZA200102961B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0103968A2 (hu) | 2002-04-29 |
| FR2784584A1 (fr) | 2000-04-21 |
| BR9914532A (pt) | 2001-11-06 |
| ZA200102961B (en) | 2001-11-20 |
| EP1121100A1 (fr) | 2001-08-08 |
| ATE237310T1 (de) | 2003-05-15 |
| JP3911125B2 (ja) | 2007-05-09 |
| AU756441B2 (en) | 2003-01-16 |
| CA2346567A1 (fr) | 2000-04-20 |
| NZ510776A (en) | 2002-10-25 |
| KR20010073214A (ko) | 2001-07-31 |
| HUP0103968A3 (en) | 2002-06-28 |
| JP2002527374A (ja) | 2002-08-27 |
| NO20011673L (no) | 2001-04-03 |
| DE69907005T2 (de) | 2004-03-18 |
| EA003069B1 (ru) | 2002-12-26 |
| CN1323198A (zh) | 2001-11-21 |
| PT1121100E (pt) | 2003-07-31 |
| ES2197672T3 (es) | 2004-01-01 |
| DE69907005D1 (de) | 2003-05-22 |
| FR2784584B1 (fr) | 2002-09-20 |
| EA200100316A1 (ru) | 2002-02-28 |
| EP1121100B1 (fr) | 2003-04-16 |
| DK1121100T3 (da) | 2003-07-21 |
| PL347322A1 (en) | 2002-03-25 |
| NO20011673D0 (no) | 2001-04-03 |
| HK1040201A1 (zh) | 2002-05-31 |
| CA2346567C (fr) | 2005-06-14 |
| AU6096799A (en) | 2000-05-01 |
| WO2000021503A1 (fr) | 2000-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60115499T2 (de) | Estrogen-zyklodextrin komplexe-zusammensetzungen | |
| JP6697473B2 (ja) | 酢酸アビラテロンの複合体、その製造のための方法、およびそれらを含有する医薬組成物 | |
| EP1978927A1 (de) | Filmförmige arzneiformen zur anwendung in der mundhöhle (wafer) | |
| US5798338A (en) | Solid dosage forms that contain clathrates of 17α-ethinyl estradiol | |
| JP2004518656A5 (https=) | ||
| HU181703B (en) | Process for producing aqueus solutuins of water insoluble or hardly soluble vitamines, steroides, localanesthetics, prostanoides and non-steroid and antiphlogistic agents | |
| US20030212043A1 (en) | Cyclodextrin-drospirenone inclusion complexes | |
| EP1461043A1 (en) | Oral pharmaceutical products containing 17 beta-estradiol-3 lower alkanoate, method of administering the same and process of preparation | |
| US7029657B2 (en) | Nasal spray steroid formulation and method | |
| KR100462441B1 (ko) | 성 호르몬 및 시클로덱스트린을 포함하는 비강 분무액을 제조하는 방법 | |
| CA3071421A1 (en) | Pharmaceutical composition comprising abiraterone acetate and darulotamide | |
| JPS62123196A (ja) | プレドニゾロン包接化合物 | |
| NO780799L (no) | Fremgangsmaate til fremstilling av et fast steroid-preparat | |
| MXPA01003410A (en) | Method for preparing a solution for nasal spray containing sex hormones and a cyclodextrin | |
| DE19848303A1 (de) | Kombination aus Gestagenen und Zuckern | |
| CN109381424A (zh) | 稳定的黄体酮水溶注射剂及其制备方法 | |
| JPS59116212A (ja) | インドメタシン外用クリ−ム剤およびその製法 | |
| JPH05178883A (ja) | カテコールエストロゲンのシクロデキストリン包接複合体及びその用途 | |
| TWI283583B (en) | Cyclodextrin-drospirenone inclusion complexes | |
| CN110694075A (zh) | 一种醋酸乌利司他-环糊精包合物的制备方法 | |
| HK1044486A1 (zh) | 使用性激素来获得可用於治疗不合需要的子宫出血的鼻腔药物组合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
St.27 status event code: A-0-1-A10-A15-nap-PA0105 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| N231 | Notification of change of applicant | ||
| PN2301 | Change of applicant |
St.27 status event code: A-3-3-R10-R13-asn-PN2301 St.27 status event code: A-3-3-R10-R11-asn-PN2301 |
|
| A201 | Request for examination | ||
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
| R18-X000 | Changes to party contact information recorded |
St.27 status event code: A-3-3-R10-R18-oth-X000 |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |
|
| T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
St.27 status event code: A-1-2-D10-D22-exm-PE0701 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
St.27 status event code: A-2-4-F10-F11-exm-PR0701 |
|
| PR1002 | Payment of registration fee |
St.27 status event code: A-2-2-U10-U12-oth-PR1002 Fee payment year number: 1 |
|
| PG1601 | Publication of registration |
St.27 status event code: A-4-4-Q10-Q13-nap-PG1601 |
|
| FPAY | Annual fee payment |
Payment date: 20071012 Year of fee payment: 4 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 4 |
|
| LAPS | Lapse due to unpaid annual fee | ||
| PC1903 | Unpaid annual fee |
St.27 status event code: A-4-4-U10-U13-oth-PC1903 Not in force date: 20081210 Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE |
|
| R18-X000 | Changes to party contact information recorded |
St.27 status event code: A-5-5-R10-R18-oth-X000 |
|
| PC1903 | Unpaid annual fee |
St.27 status event code: N-4-6-H10-H13-oth-PC1903 Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE Not in force date: 20081210 |